Moreover, Ang II-induced overexpression of critical genes involved in aneurysm pathogenesis—such as VEGF, MMP-2, MMP-9, HMGB1, and NF-κB p65—was significantly downregulated following CL treatment. The gene discussed is HMGB1; the disease is aneurysm.